Nanodigmbio (Nanjing) Biotechnology Co., Ltd.

Nanodigmbio believes in Nano Trans More, dedicated to creating more value and serving diagnosis in the field of targeted sequencing. Nanodigmbio is committed to providing specialized and high-quality products and ready-for-use solutions for academic institutions, medical institutions, NGS industrial companies etc.Nanodigmbio has complete series of products in targeted sequencing, including kinds of library preparation kits and liquid phase hybridization reagents, compatible with MGI and illumina platforms. Nanodigmbio provides optimized panels for applications in precision medicine and research, including exome research panel, pan-cancer research panel, hemooncology research panel and respirovirus research panel, and excellent customized panel validated by NGS. Nanodimbio owns a R&D center of over 2,000 m2 and a GMP manufacturing facility (YY/T0287-2017idt ISO13485:2016) of over 2,500 m2, ensuring high innovation R&D and production.